MY119643A - Pharmaceutical compositions containing eletriptan hemisulphate and caffeine - Google Patents

Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Info

Publication number
MY119643A
MY119643A MYPI98002961A MYPI9802961A MY119643A MY 119643 A MY119643 A MY 119643A MY PI98002961 A MYPI98002961 A MY PI98002961A MY PI9802961 A MYPI9802961 A MY PI9802961A MY 119643 A MY119643 A MY 119643A
Authority
MY
Malaysia
Prior art keywords
caffeine
pharmaceutical compositions
compositions containing
eletriptan hemisulphate
containing eletriptan
Prior art date
Application number
MYPI98002961A
Other languages
English (en)
Inventor
Valerie Denise Harding
Anne Billotte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MY119643A publication Critical patent/MY119643A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Packaging Of Annular Or Rod-Shaped Articles, Wearing Apparel, Cassettes, Or The Like (AREA)
MYPI98002961A 1997-07-03 1998-06-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine MY119643A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9714081.8A GB9714081D0 (en) 1997-07-03 1997-07-03 Pharmaceutical compositions
GBGB9718270.3A GB9718270D0 (en) 1997-07-03 1997-08-28 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MY119643A true MY119643A (en) 2005-06-30

Family

ID=10815339

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI98002961A MY119643A (en) 1997-07-03 1998-06-30 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine

Country Status (13)

Country Link
KR (1) KR100384346B1 (ko)
AP (1) AP1100A (ko)
AR (1) AR013165A1 (ko)
CO (1) CO4950555A1 (ko)
GB (2) GB9714081D0 (ko)
GT (1) GT199800105A (ko)
HN (1) HN1998000101A (ko)
MY (1) MY119643A (ko)
PA (1) PA8454501A1 (ko)
PE (1) PE84499A1 (ko)
TN (1) TNSN98126A1 (ko)
UA (1) UA49955C2 (ko)
ZA (1) ZA985812B (ko)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9417310D0 (en) * 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
UA49955C2 (uk) 2002-10-15
GB9718270D0 (en) 1997-11-05
AP9801290A0 (en) 1998-09-30
PA8454501A1 (es) 2000-05-24
GT199800105A (es) 2000-01-04
CO4950555A1 (es) 2000-09-01
PE84499A1 (es) 1999-09-11
TNSN98126A1 (fr) 2005-03-15
AR013165A1 (es) 2000-12-13
ZA985812B (en) 2000-01-10
HN1998000101A (es) 1999-01-08
KR100384346B1 (ko) 2003-05-16
GB9714081D0 (en) 1997-09-10
KR20010014366A (ko) 2001-02-26
AP1100A (en) 2002-09-02

Similar Documents

Publication Publication Date Title
HRP990416B1 (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
MY125556A (en) Aqueous formulations of peptide
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
BR9713699A (pt) Preparado cosmético com um aditivo de peptìdio e utilização do mesmo
ZA97858B (en) Compositions containing immunogenic molecules and granulocyte-macrophage colony stimulating factor, as an adjuvant.
MY118371A (en) Tetrahydrolipstatin containing compositions
EP0902789A4 (ko)
HU229458B1 (en) Pharmaceutical compositions containing zolmitriptan
EP1140900A4 (en) PYRAZOLE COMPOUNDS AND USE OF SUCH COMPOUNDS
BG106155A (en) Novel derivatives and analogues of galanthamin
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
MY119643A (en) Pharmaceutical compositions containing eletriptan hemisulphate and caffeine
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
NZ331083A (en) Pharmaceutical preparations of cilansetron stabilized against racemization
AU2809697A (en) Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
GEP20032975B (en) Echinocandin Derivatives, Preparation Method and Pharmaceutical Composition
HK1036413A1 (en) Solution comprising prostaglandins and benzyl alcohol.
IT1314204B1 (it) Complessi di rutenio con elevata attivita' antitumorale